Page 69 - Read Online
P. 69

Page 12 of 16                      Bookland et al. J Cancer Metastasis Treat 2019;5:33  I  http://dx.doi.org/10.20517/2394-4722.2018.110

               Table 2. Summary of select works identifying circulating biomarkers for pediatric brain tumors
                Source          Marker(s)            Method        Tumor type         Finding         Ref.
                CSF      Type 1 collagen        LC-MS/MS, RPPA, ELiSA Mixed Brain Tumors Protein signatures may discriminate  [98]
                         iGFBP4                                               metastatic tumors from controls
                         Procollagen C-endopeptidase
                         enhance 1
                         Glial cell-line derived neurotrophic
                         factor receptor α2
                         inter-alpha-trypsin inhibitor heavy
                         chain 4
                         Neural proliferation and
                         differentiation control protein-1
                CSF      H3F3A /HiSTiH313 mutations  Sanger sequencing  Diffuse midline   Feasibility and specificity of   [34]
                                                (DNA isolation, nested   glioma  H3K27M detection in DNA from
                                                PCR) of cfDNA                 CSF
                CSF      Prostaglandin D2 synthase  Proteomics  Medulloblastoma  PGD2S ↓             [64]
                                                MALDi-TOF/ELiSA
                CSF      Apolipoprotein A-ii    SELDi-TOF mass   Brain tumor  ApoAii level ↑         [59]
                                                spectrometry
                CSF      LVV                    Proteomics LC-MS  Mixed Brain Tumors LVV-/VV-h7 ↓ in tumor patients  [62]
                         VV-hemorphin-7
                CSF      c-Tau                  ELiSA           Medulloblastoma  c-Tau ↑             [99]
                                                                Ependymoma
                                                                Astrocytoma
                CSF      CyclophillinA Dimethyarginase 1  Proteomics, mass   DiPG  ↑ cCypA and DDAH1  [63]
                                                spectrometry
                CSF      cfDNA                  Genome-wide     High Grade Glioma  cfDNA detected in 74% of tumor   [36]
                                                sequencing      JPA           patient CSF
                                                                Medulloblastoma
                                                                Ependymoma
                CSF, serum  Human chorionic gonadotropin  Enzyme immunoassay  Germinoma  HCG ↑ in patients with recurrence   [22]
                                                                              events
                CSF, plasma  iGF, iGFBPs, iGFRs  Microarray, RiA, western Ependymoma  iGFBP-2/iGFBP-3 ↑ tumor patients  [61]
                                                                Medulloblastoma
                CSF, plasma  Osteopontin        ELiSA, qPCR     Medullbolastoma  Osteopontin ↑ in AT/RT recurrence  [84]
                                                                AT/RT
                CSF, serum  AFP                 immunoenzyme    Germinoma NGGCT ↑ AFP in serum       [20]
                         beta-hCG                                             ↑ bHCG in CSF
                CSF, serum  miR-371a-3p         qRT-PCR         Germ cell tumors  miRNA ↑            [100]
                         miR-372-3p
                         miR-373-3p
                         miR-367-3p
                CSF, plasma  H3K27M-mutant cfDNA  Digital drople PCR  Diffuse midline   H3K27M mutant cfDNA correlates  [35]
                                                                glioma        with treatment response
                Blood/serum ERCC2 methylation   illumina Beadchip  Medulloblastoma  ERCC2 promoter methylation ↑   [101]
                                                                              correlates with poor prognosis
                Serum    Metallothionein        Differential pulse   Medulloblastoma  ↑ in cancer patient’s serum  [88]
                                                voltametry      Ependymoma
                Blood/serum miRNA profile       qPCR            JPA           ↑miR21, mir15b,        [41]
                                                                              miR23, miR146b correlated with
                                                                              tumor mural nodule size
                Serum    VEGF                   ELiSA           High grade glioma  VEGF ↑            [89]
                         bFGF
                Urine, CSF  MMP-2               ELiSA           JPA           MMP-2, MMP-9, MMP-NGAL,   [94]
                         MMP-9                                                VEGF levels ↑
                         MMP-NGAL
                         VEGF
                Urine    bFGF                   ELiSA           JPA           bFGF, TiMP3 ↑          [93]
                         TiMP3                                                MMP-13 ↓
                         MMP-13
                Urine    Netrin-1               ELiSA           Medulloblastoma  Netrin-1 ↑ in metastatic   [102]
                                                                              medulloblastoma

               CSF: cerebrospinal fluid; cfDNA: cell-free tumor DNA; iGF: insulin-like growth factor; iGFBPs: iGF binding proteins; VEGF: vascular
               endothelial growth factor; bFGF: basic fibroblast growth factor
   64   65   66   67   68   69   70   71   72   73   74